Compile Data Set for Download or QSAR
maximum 50k data
Found 187 of ec50 data for polymerid = 50007055
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610712(US10626095, Example 24)
Affinity DataEC50:  0nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610832(US10626095, Example 138)
Affinity DataEC50:  62nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610698(US10626095, Example 10)
Affinity DataEC50:  70nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610828(US10626095, Example 134)
Affinity DataEC50:  85nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610725(US10626095, Example 37)
Affinity DataEC50:  120nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610694(US10626095, Example 7)
Affinity DataEC50:  170nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610826(US10626095, Example 133)
Affinity DataEC50:  190nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610692(US10626095, Example 5)
Affinity DataEC50:  200nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610834(US10626095, Example 139)
Affinity DataEC50:  210nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610796(US10626095, Example 103)
Affinity DataEC50:  230nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610697(US10626095, Example 9)
Affinity DataEC50:  230nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610755(US10626095, Example 64)
Affinity DataEC50:  240nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610691(US10626095, Example 4)
Affinity DataEC50:  240nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610690(US10626095, Example 3)
Affinity DataEC50:  260nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610818(US10626095, Example 126)
Affinity DataEC50:  260nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610721(US10626095, Example 33)
Affinity DataEC50:  270nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610689(US10626095, Example 2)
Affinity DataEC50:  280nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610696(US10626095, Example 8)
Affinity DataEC50:  290nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610764(US10626095, Example 72)
Affinity DataEC50:  300nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610750(US10626095, Example 60)
Affinity DataEC50:  300nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610825(US10626095, Example 132)
Affinity DataEC50:  320nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610723(US10626095, Example 35)
Affinity DataEC50:  340nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610847(US10626095, Example 220)
Affinity DataEC50:  350nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610795(US10626095, Example 102)
Affinity DataEC50:  360nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610716(US10626095, Example 28)
Affinity DataEC50:  370nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610841(US10626095, Example 145)
Affinity DataEC50:  370nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610719(US10626095, Example 31)
Affinity DataEC50:  380nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610729(US10626095, Example 41)
Affinity DataEC50:  390nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610693(US10626095, Example 6)
Affinity DataEC50:  400nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610842(US10626095, Example 146)
Affinity DataEC50:  410nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610726(US10626095, Example 38)
Affinity DataEC50:  420nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610801(US10626095, Example 108)
Affinity DataEC50:  420nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610883(US10626095, Example 1505)
Affinity DataEC50:  420nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610853(US10626095, Example 600)
Affinity DataEC50:  430nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610744(US10626095, Example 54)
Affinity DataEC50:  430nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610856(US10626095, Example 613)
Affinity DataEC50:  430nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610737(US10626095, Example 48)
Affinity DataEC50:  430nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610752(US10626095, Example 61)
Affinity DataEC50:  440nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610739(US10626095, Example 50)
Affinity DataEC50:  440nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610823(US10626095, Example 131)
Affinity DataEC50:  440nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610821(US10626095, Example 129)
Affinity DataEC50:  440nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610807(US10626095, Example 114)
Affinity DataEC50:  450nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610711(US10626095, Example 23)
Affinity DataEC50:  450nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610854(US10626095, Example 607)
Affinity DataEC50:  450nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610724(US10626095, Example 36)
Affinity DataEC50:  450nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610722(US10626095, Example 34)
Affinity DataEC50:  460nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610760(US10626095, Example 68)
Affinity DataEC50:  460nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610747(US10626095, Example 57)
Affinity DataEC50:  480nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610857(US10626095, Example 617)
Affinity DataEC50:  480nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610738(US10626095, Example 49)
Affinity DataEC50:  480nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 187 total ) | Next | Last >>
Jump to: